公开(公告)号：EP2364710B1

公开(公告)日：2018-11-28

申请号：EP11169415.4

申请日：2003-05-22

申请人： National University Corporation Kagawa University ,  Matsutani Chemical Industry Co., Ltd.

发明人： Izumori, Ken ,  Tokuda, Masaaki ,  Itano, Toshifumi ,  Miyamoto, Osamu ,  Ishida, Toshihiko ,  Murao, Koji ,  Tasaka, Taizo ,  Muneuchi, Gan ,  Yamaguchi, Fuminori ,  Tanaka, Terukazu ,  Hossain, Mohammed, Akram ,  Ueki, Masaaki ,  Hirooka, Kazuyuki ,  Taminato, Asahiko ,  Tsusaki, Keiji ,  Takahashi, Takeo ,  Nagata, Mitsuhiro ,  Ishida, Yutaka

IPC分类号： A61K8/60 ,  A61Q19/00 ,  A23L29/30 ,  A23L33/10 ,  A23L5/00 ,  A23L33/125 ,  A61K31/7004

CPC分类号： A61Q19/00 ,  A23L5/00 ,  A23L29/30 ,  A23L33/10 ,  A23L33/125 ,  A61K8/60 ,  A61K31/7004

摘要： A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.

公开(公告)号：EP2364710A1

公开(公告)日：2011-09-14

申请号：EP11169415.4

申请日：2003-05-22

申请人： Fushimi Pharmaceutical Company, Limited ,  TEIKOKU SEIYAKU CO., LTD. ,  National University Corporation Kagawa University

发明人： Izumori, Ken ,  Tokuda, Masaaki ,  Itano, Toshifumi ,  Miyamoto, Osamu ,  Ishida, Toshihiko ,  Murao, Koji ,  Tasaka, Taizo ,  Muneuchi, Gan ,  Yamaguchi, Fuminori ,  Tanaka, Terukazu ,  Hossain, Mohammed, Akram ,  Ueki, Masaaki ,  Hirooka, Kazuyuki ,  Taminato, Asahiko ,  Tsusaki, Keiji ,  Takahashi, Takeo ,  Nagata, Mitsuhiro ,  Ishida, Yutaka

IPC分类号： A61K31/7004 ,  A61P35/00 ,  A61P39/06 ,  A61P25/00 ,  A61P9/10 ,  A61P27/02

CPC分类号： A61Q19/00 ,  A23L5/00 ,  A23L29/30 ,  A23L33/10 ,  A23L33/125 ,  A61K8/60 ,  A61K31/7004

摘要： A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells.

摘要翻译： 利用稀有糖类的生理活性的方法，其中用稀有糖类处理生理活性敏感性细胞以改变细胞的功能。 作为活性成分含有引入生理活性敏感性细胞的稀有糖类并具有改变细胞功能的作用的组合物。 细胞是人类细胞。 组合物是功能性食品，药物或化妆品。 稀有的糖是D-丙氨酸，细胞选自癌细胞增殖抑制活性敏感细胞和活性氧生成抑制活性敏感细胞。